MELISSA CORDOVA ROSADO: Open Payments
NPI 1073255121 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 15 payments from 7 companies in 2025. Trend: 2023 $21 · 2024 $95 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $142 |
| Ipsen Biopharmaceuticals, Inc | 1 | $141 |
| ABBVIE INC. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $26 |
Products named: IQIRVO, VELSIPITY, XELJANZ, TREMFYA, XIFAXAN, OMVOH, MAVYRET, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
